能倍乐和思力华的差别

The difference between Respimat and Sliva: Respimat is also called Sliva. The two names correspond to the same drug, so there is no difference.

Respimat was developed by Boehringer Ingelheim and has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic obstructive pulmonary disease (COPD), making it easier for them to breathe. COPD is a long-term lung disease that causes shortness of breath and coughing. Respimat helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

Respimat is effective 24 hours a day, so it only needs to be used once a day, if possible at the same time every day. Spray twice with each use. It should be noted that patients should not overdose to avoid harm to the body.

The concomitant use of Respimat with some medicines may lead to an exacerbation of side effects, for example any medicine that may be similar to Respimat (containing similar active substances, such as anticholinergics or beta-adrenergic medicines). Beta-blocker drugs, used to treat high blood pressure or other heart problems (such as propranolol), or to treat glaucoma (such as timolol), may cause Respimat to lose effectiveness, so patients should talk to their doctor first if they need to use other drugs.

This medicine is contraindicated if the patient is allergic to it or its components. Some patients may experience immediate allergic reactions after using Respimat, such as rash, hives, swelling of the mouth and face, sudden difficulty breathing (angioedema), or other allergic reactions (such as a sudden drop in blood pressure or dizziness) that may occur alone or as part of a severe allergic reaction. If any of the above conditions occur, stop using this medicine and consult your doctor immediately.

Recommended related hot articles: /newsDetail/82316.html